Bernhard Hemmer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bernhard Hemmer. Real-time updates on events, politics, business and more.

Biosimilar Equal to Natalizumab for Relapsing-Remitting MS

January 27, 2023

A novel biosimilar matches natalizumab in terms of efficacy, safety, and immunogenicity in patients with relapsing remitting multiple sclerosis, results from a new phase 3 trial show.

John Cunningham Janicem Neely Polpharma Biologics Torge Rempe Bernhard Hemmer Technical University Of Munich

Source: medscape.com

Technical University of Munich: Interdisciplinary research for the digital medicine of the future

July 7, 2022

The Zentrum für Digitale Medizin und Gesundheit (ZDMG) will bring together researchers in medicine, informatics and mathematics. They will collaborate on new healthcare developments based on data science and artificial intelligence and pursue clinica

Markus Blume Bernhard Hemmer Martin Siess Technical University Of Munich German Council Of Science School Of Medicine Health

Source: indiaeducationdiary.in

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Bernhard Hemmer News Today

Biosimilar Equal to Natalizumab for Relapsing-Remitting MS

Technical University of Munich: Interdisciplinary research for the digital medicine of the future

Explore More Categories